An Investigational New Drug Application (IND) is a request for authorization from the Food and Drug Administration (FDA) to administer an investigational drug or biological product to humans.
Recommend0 recommendationsPublished in US National Health Agency Sources
The Food and Drug Administration (FDA) recently announced its request for $7.2 billion as part of President Joe Biden’s fiscal year (FY) 2025 proposed budget. FDA’s request, which is about 7% higher than last year, covers the agency’s top health priorities. “This funding will allow the agency to enhance food safety and nutrition, advance medical …
The post FDA’s Big Plan to Enhance Public Health in 2025 appeared first on Salud America.
We all want the best for our children. While the thought of enrolling your child in a clinical trial may sound scary, but there are plenty of benefits to trial participation. Some of these benefits include diagnosing, preventing, treating, and sometimes even curing childhood diseases. However, there are some potential risks to trial participation, too. …
The post Is a Clinical Trial Right for Your Child? appeared first on Salud America.
The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health…
When the FDA announced in January, before President Joe Biden’s term ended, that it would ban a dye called red dye No. 3 in food…
The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
